The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results

Authors: Albanese, G.V.; Pizzo, T.; Galvano, A.; Piazza, D.; Macaluso, S.; Provenzano, S.; Badalamenti, G.; Intrivici, C.; Fulfaro, F.; Gebbia, N.
Publication year: 2010
Type: Abstract in atti di convegno pubblicato in rivista
Key words: bladder cancer,
OA Link: http://hdl.handle.net/10447/58510